WAY-100635: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
 
CSV import
 
Line 1: Line 1:
'''WAY-100635''' is a compound that is used in scientific research. It acts as an antagonist for the [[5-HT1A receptor]], and has been used in the development of various drugs. WAY-100635 is also a potent and selective [[5-HT1A receptor]] antagonist, with a Ki of 0.91 nM at the human 5-HT1A receptor and over 100-fold selectivity over other receptors.
== WAY-100635 ==


== History ==
[[File:WAY-100,635.png|thumb|right|Chemical structure of WAY-100635]]
WAY-100635 was first synthesized in the early 1990s by the pharmaceutical company [[Warner-Lambert]]. It was initially developed as a potential treatment for [[depression]] and [[anxiety]], but its use has since expanded to include research into other areas of neuroscience.
 
'''WAY-100635''' is a chemical compound that acts as a selective antagonist of the [[5-HT1A receptor]], a subtype of the [[serotonin receptor]]. It is widely used in scientific research to study the role of 5-HT1A receptors in various physiological and pathological processes.


== Pharmacology ==
== Pharmacology ==
WAY-100635 is a potent and selective antagonist for the 5-HT1A receptor. It has a high affinity for this receptor, with a Ki of 0.91 nM. This makes it one of the most potent 5-HT1A receptor antagonists currently available. In addition to its high affinity, WAY-100635 also has over 100-fold selectivity for the 5-HT1A receptor over other receptors.


== Uses ==
WAY-100635 is known for its high affinity and selectivity for the 5-HT1A receptor. It binds to this receptor and blocks the action of [[serotonin]], a neurotransmitter that plays a crucial role in mood regulation, anxiety, and other central nervous system functions. By inhibiting the 5-HT1A receptor, WAY-100635 is used to investigate the effects of serotonin in the brain and to explore potential therapeutic targets for psychiatric disorders.
WAY-100635 is primarily used in scientific research. It is often used in studies investigating the role of the 5-HT1A receptor in various neurological and psychiatric disorders. These include depression, anxiety, schizophrenia, and Parkinson's disease.
 
== Uses in Research ==
 
In [[neuroscience]] research, WAY-100635 is employed to understand the involvement of 5-HT1A receptors in various conditions such as [[depression]], [[anxiety disorders]], and [[schizophrenia]]. It is also used in [[preclinical studies]] to evaluate the efficacy of new drugs targeting the serotonin system.
 
=== Imaging Studies ===
 
[[File:WAY-100,635.png|thumb|left|Molecular structure of WAY-100635]]
 
WAY-100635 is utilized in [[positron emission tomography]] (PET) imaging studies to visualize and quantify 5-HT1A receptor distribution in the brain. Radiolabeled derivatives of WAY-100635, such as [11C]WAY-100635, are used as tracers in these imaging studies, providing valuable insights into receptor density and function in both healthy and diseased states.
 
== Mechanism of Action ==
 
As a 5-HT1A receptor antagonist, WAY-100635 prevents serotonin from binding to and activating this receptor. The 5-HT1A receptor is a [[G protein-coupled receptor]] that, when activated by serotonin, can inhibit the release of certain neurotransmitters and modulate neuronal excitability. By blocking this receptor, WAY-100635 can alter neurotransmitter release and neuronal activity, which is useful for dissecting the role of serotonin in various neural circuits.
 
== Related Pages ==


== See also ==
* [[Serotonin receptor]]
* [[5-HT1A receptor]]
* [[5-HT1A receptor]]
* [[Antagonist (biochemistry)]]
* [[Neurotransmitter]]
* [[Neuroscience]]
* [[G protein-coupled receptor]]


== References ==
[[Category:Pharmacology]]
<references />
 
[[Category:Drugs]]
[[Category:Neuroscience]]
[[Category:Neuroscience]]
[[Category:Pharmacology]]
[[Category:Serotonin receptor antagonists]]
{{stub}}

Latest revision as of 03:40, 13 February 2025

WAY-100635[edit]

Chemical structure of WAY-100635

WAY-100635 is a chemical compound that acts as a selective antagonist of the 5-HT1A receptor, a subtype of the serotonin receptor. It is widely used in scientific research to study the role of 5-HT1A receptors in various physiological and pathological processes.

Pharmacology[edit]

WAY-100635 is known for its high affinity and selectivity for the 5-HT1A receptor. It binds to this receptor and blocks the action of serotonin, a neurotransmitter that plays a crucial role in mood regulation, anxiety, and other central nervous system functions. By inhibiting the 5-HT1A receptor, WAY-100635 is used to investigate the effects of serotonin in the brain and to explore potential therapeutic targets for psychiatric disorders.

Uses in Research[edit]

In neuroscience research, WAY-100635 is employed to understand the involvement of 5-HT1A receptors in various conditions such as depression, anxiety disorders, and schizophrenia. It is also used in preclinical studies to evaluate the efficacy of new drugs targeting the serotonin system.

Imaging Studies[edit]

Molecular structure of WAY-100635

WAY-100635 is utilized in positron emission tomography (PET) imaging studies to visualize and quantify 5-HT1A receptor distribution in the brain. Radiolabeled derivatives of WAY-100635, such as [11C]WAY-100635, are used as tracers in these imaging studies, providing valuable insights into receptor density and function in both healthy and diseased states.

Mechanism of Action[edit]

As a 5-HT1A receptor antagonist, WAY-100635 prevents serotonin from binding to and activating this receptor. The 5-HT1A receptor is a G protein-coupled receptor that, when activated by serotonin, can inhibit the release of certain neurotransmitters and modulate neuronal excitability. By blocking this receptor, WAY-100635 can alter neurotransmitter release and neuronal activity, which is useful for dissecting the role of serotonin in various neural circuits.

Related Pages[edit]